RN7SL182P

Across TCGA pan-cancer cohorts, RN7SL182P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RN7SL182P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RN7SL182P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL182P expression acts as an unfavorable survival marker, although some lineages such as COAD and BRCA show a favorable association.

THCA, TGCT, and COAD are the cancer types where RN7SL182P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	II,III,IV	0.519	0.771	<.001	60	view →
TGCT	DFS	Tertile	All	0.624	0.859	<.001	54	view →
COAD	DFS	Tertile	All	0.901	0.737	.002	48	view →
KIRC	DFS	Tertile	IV	0.327	0.641	.011	39	view →
DLBC	DFS	Median	III,IV	0.140	0.917	.010	38	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	37	view →
SARC	DFS	Tertile	All	0.347	0.588	.001	27	view →
BRCA	OS	Tertile	III,IV	0.969	0.877	.003	26	view →
LAML	DFS	Tertile	All	0.593	0.238	.009	24	view →
BLCA	OS	Tertile	III,IV	0.723	0.625	.033	20	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
UCEC	OS	Quartile	All	0.897	0.941	.012	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RN7SL182P–THCA (DFS)

Open the THCA breakdown →